The molecular profile of mucosal melanoma

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

The molecular profile of mucosal melanoma. / Mikkelsen, Lauge Hjorth; Maag, Emil; Andersen, Mette Klarskov; Kruhøffer, Mogens; Larsen, Ann Cathrine; Melchior, Linea Cecilie; Toft, Peter Bjerre; von Buchwald, Christian; Wadt, Karin; Heegaard, Steffen.

I: Melanoma Research, Bind 30, Nr. 6, 2020, s. 533-542.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Mikkelsen, LH, Maag, E, Andersen, MK, Kruhøffer, M, Larsen, AC, Melchior, LC, Toft, PB, von Buchwald, C, Wadt, K & Heegaard, S 2020, 'The molecular profile of mucosal melanoma', Melanoma Research, bind 30, nr. 6, s. 533-542. https://doi.org/10.1097/CMR.0000000000000686

APA

Mikkelsen, L. H., Maag, E., Andersen, M. K., Kruhøffer, M., Larsen, A. C., Melchior, L. C., Toft, P. B., von Buchwald, C., Wadt, K., & Heegaard, S. (2020). The molecular profile of mucosal melanoma. Melanoma Research, 30(6), 533-542. https://doi.org/10.1097/CMR.0000000000000686

Vancouver

Mikkelsen LH, Maag E, Andersen MK, Kruhøffer M, Larsen AC, Melchior LC o.a. The molecular profile of mucosal melanoma. Melanoma Research. 2020;30(6):533-542. https://doi.org/10.1097/CMR.0000000000000686

Author

Mikkelsen, Lauge Hjorth ; Maag, Emil ; Andersen, Mette Klarskov ; Kruhøffer, Mogens ; Larsen, Ann Cathrine ; Melchior, Linea Cecilie ; Toft, Peter Bjerre ; von Buchwald, Christian ; Wadt, Karin ; Heegaard, Steffen. / The molecular profile of mucosal melanoma. I: Melanoma Research. 2020 ; Bind 30, Nr. 6. s. 533-542.

Bibtex

@article{54802a1de82e4c46972437fd0c78dabd,
title = "The molecular profile of mucosal melanoma",
abstract = "Herein, we wanted to explore the molecular landscape of mucosal melanoma from different sites and identify potential molecular targets for future therapy. Mucosal melanomas (N = 40) from different sites (conjunctiva, sinonasal cavity, rectum, and vagina) were investigated. Targeted next-generation sequencing along with Nanostring gene expression profiling was performed. Genetically, conjunctival melanoma was characterized by BRAF-V600E (30%) and NF1 mutations (17%). Mucosal melanomas at nonsun-exposed sites harbored alterations in NRAS, KIT, NF1, along with atypical BRAF mutations. When comparing the gene expression profile of conjunctival melanoma and nonsun-exposed mucosal melanoma, 41 genes were found to be significantly deregulated. Programmed death-ligand 1 (PD-L1) presented a significant sixfold upregulation in conjunctival melanoma compared to the other mucosal melanomas. While melanomas of the sinonasal cavity, vagina, and rectum are molecularly similar, conjunctival melanoma is characterized by a higher frequency of BRAF-V600E mutations and differential expression of several genes involved in the immune response.",
author = "Mikkelsen, {Lauge Hjorth} and Emil Maag and Andersen, {Mette Klarskov} and Mogens Kruh{\o}ffer and Larsen, {Ann Cathrine} and Melchior, {Linea Cecilie} and Toft, {Peter Bjerre} and {von Buchwald}, Christian and Karin Wadt and Steffen Heegaard",
year = "2020",
doi = "10.1097/CMR.0000000000000686",
language = "English",
volume = "30",
pages = "533--542",
journal = "Melanoma Research",
issn = "0960-8931",
publisher = "Lippincott Williams & Wilkins, Ltd.",
number = "6",

}

RIS

TY - JOUR

T1 - The molecular profile of mucosal melanoma

AU - Mikkelsen, Lauge Hjorth

AU - Maag, Emil

AU - Andersen, Mette Klarskov

AU - Kruhøffer, Mogens

AU - Larsen, Ann Cathrine

AU - Melchior, Linea Cecilie

AU - Toft, Peter Bjerre

AU - von Buchwald, Christian

AU - Wadt, Karin

AU - Heegaard, Steffen

PY - 2020

Y1 - 2020

N2 - Herein, we wanted to explore the molecular landscape of mucosal melanoma from different sites and identify potential molecular targets for future therapy. Mucosal melanomas (N = 40) from different sites (conjunctiva, sinonasal cavity, rectum, and vagina) were investigated. Targeted next-generation sequencing along with Nanostring gene expression profiling was performed. Genetically, conjunctival melanoma was characterized by BRAF-V600E (30%) and NF1 mutations (17%). Mucosal melanomas at nonsun-exposed sites harbored alterations in NRAS, KIT, NF1, along with atypical BRAF mutations. When comparing the gene expression profile of conjunctival melanoma and nonsun-exposed mucosal melanoma, 41 genes were found to be significantly deregulated. Programmed death-ligand 1 (PD-L1) presented a significant sixfold upregulation in conjunctival melanoma compared to the other mucosal melanomas. While melanomas of the sinonasal cavity, vagina, and rectum are molecularly similar, conjunctival melanoma is characterized by a higher frequency of BRAF-V600E mutations and differential expression of several genes involved in the immune response.

AB - Herein, we wanted to explore the molecular landscape of mucosal melanoma from different sites and identify potential molecular targets for future therapy. Mucosal melanomas (N = 40) from different sites (conjunctiva, sinonasal cavity, rectum, and vagina) were investigated. Targeted next-generation sequencing along with Nanostring gene expression profiling was performed. Genetically, conjunctival melanoma was characterized by BRAF-V600E (30%) and NF1 mutations (17%). Mucosal melanomas at nonsun-exposed sites harbored alterations in NRAS, KIT, NF1, along with atypical BRAF mutations. When comparing the gene expression profile of conjunctival melanoma and nonsun-exposed mucosal melanoma, 41 genes were found to be significantly deregulated. Programmed death-ligand 1 (PD-L1) presented a significant sixfold upregulation in conjunctival melanoma compared to the other mucosal melanomas. While melanomas of the sinonasal cavity, vagina, and rectum are molecularly similar, conjunctival melanoma is characterized by a higher frequency of BRAF-V600E mutations and differential expression of several genes involved in the immune response.

U2 - 10.1097/CMR.0000000000000686

DO - 10.1097/CMR.0000000000000686

M3 - Journal article

C2 - 33156594

AN - SCOPUS:85095802573

VL - 30

SP - 533

EP - 542

JO - Melanoma Research

JF - Melanoma Research

SN - 0960-8931

IS - 6

ER -

ID: 258378054